会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • COMPOSITIONS AND METHODS FOR THE TREAMENT OF INFLAMMATORY DISEASE
    • 炎症性疾病的组合物和方法
    • WO2010039529A3
    • 2010-05-27
    • PCT/US2009058016
    • 2009-09-23
    • RESOLVYX PHARMACEUTICALS INCGJORSTRUP PER
    • GJORSTRUP PER
    • A61P29/00A61K31/201A61K31/202A61K31/426A61K31/427A61K31/4439A61K31/536A61K31/557A61K31/616
    • A61K31/606A61K31/20A61K31/336A61K31/4439A61K45/06
    • (a) A method of treating inflammatory disease by conjointly administering a composition comprising a first agent selected from (a) a PPAR agonist, a LXR agonist, a RXR agonist, a HNF-4 agonist or a sirtuin-activating compound and a second agent selected from (b) a compound of formula A, a compound of formulae 1-49, a compound of formulae I-HI, a lipoxin compound, an oxylipin compound, or prodrug thereof, (b) A method of treating inflammatory disease by conjointly administering (i) aspirin, (ii) an omega-3 fatty acid and (iii) a PPAR, LXR, RXR, or HNF-4 agonist, or a sirtuin-activating compound, (c) A composition comprising (i) an omega-3 fatty acid and (ii) a PPAR, LXR, RXR, or HNF-4 agonist, or a sirtuin-activating compound and (iii) a pharmaceutically acceptable carrier, (d) A method of treating a patient with type-1 diabetes, at risk of developing type 1 diabetes, or exhibiting warning signs of type-1 diabetes by administering (i) a combination of aspirin and an omega-3 fatty acid or (ii) a compound of formula A, a compound of formulae 1-49, a compound of formulae I-ip, a lipoxin compound, ah oxylipin compound, or prodrug thereof.
    • (a)通过联合施用组合物来治疗炎性疾病的方法,所述组合物包含选自(a)PPAR激动剂,LXR激动剂,RXR激动剂,HNF-4激动剂或沉默调节蛋白激活化合物的第一药剂和第二药剂 选自(b)式A的化合物,式1-49的化合物,式I-HI的化合物,脂氧素化合物,氧环磷脂化合物或其前药,(b)通过联合治疗炎症性疾病的方法 (i)阿司匹林,(ii)ω-3脂肪酸和(iii)PPAR,LXR,RXR或HNF-4激动剂或沉默调节蛋白的激活化合物,(c)包含(i) -3脂肪酸和(ii)PPAR,LXR,RXR或HNF-4激动剂或沉默调节蛋白的活化化合物和(iii)药学上可接受的载体,(d)治疗1型糖尿病患者的方法 有发生1型糖尿病的危险,或出现1型糖尿病的警告征象,方法是(i)组合阿司匹林和ω-3脂肪酸o r(ii)式A的化合物,式1-49的化合物,式I-ip的化合物,脂氧素化合物,氧基联磷化合物或其前药。